JP Jenkins - The JP Jenkins-15 December Index update
14/01/2026 07:00
RNS Number : 7403O JP Jenkins 14 January 2026 The JP Jenkins-15 December Index update Index valuation approaches £2bn mark London, 14th January 2026 - The JP Jenkins (www.jpjenkins.com) proprietary index covering the performance of the venue's 15 largest stocks has been calculated after the close on 9th January. This shows the index trading up a further 5.4% at 1209.1 resulting in a 21% rise through the first year of existence. Dominique Pretorius of JP Jenkins, commented: "We launched the index a year ago and it's impressive to see its performance keeping pace with broader equity markets. Our quarterly rebalancing is ensuring the inclusion of larger market cap companies doesn't skew the calculation whilst the index has also gained traction and interest with the wider investment community." Once again, buying for THG Ingenuity was a key driver in boosting the index valuation. In the quarterly rebalancing, e-therapeutics was removed from the list following the completion of their tenure on the JP Jenkins venue, being replaced by OPG Power Ventures. Over the course of December, new inclusions to the platform included OPG Power Ventures, Polarean Imaging and Bigblu Broadband, with more than 40 companies having joined the matched bargain facility during 2025. The index is market cap weighted. Quarterly reweighting will next take place in April 2026. About JP Jenkins JP Jenkins is the UK's largest venue for unlisted assets. The company provides an efficient platform for privately held and unlisted businesses who are seeking a liquidity solution for holders of their securities. By using market-leading technology from InfinitX, any registered broker or financial institution can now connect, execute and settle with JP Jenkins over existing market infrastructures. Media contact Tony Cross Monk Communications tony@monkcommunications.com +44 (0) 7973 284749 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END JPJEADFDFFKKEFA